Topic: Astrazeneca Group
Shares in AstraZeneca rose sharply in London Wednesday after the drug company won a U.S. court ruling to protect a patent for its blockbuster cholesterol drug, Crestor. The U.S. District Court in Delaware ruled on Tuesday that a key patent for Crestor ...
Federal regulators have granted AstraZeneca approval to market its cholesterol pill Crestor as a preventive measure against heart attack and stroke in patients with healthy cholesterol levels. The Food and Drug Administration decision will allow the company to promote Crestor to millions ...
FDA panel says AstraZeneca's cholesterol pill Crestor can curb heart problemsFederal health advisers said Tuesday that expanded use of AstraZeneca's cholesterol pill Crestor can benefit patients with healthy cholesterol levels by preventing heart attack, stroke and death. A Food and Drug Administration ...
GAITHERSBURG, Maryland (Reuters) - AstraZeneca won a U.S. panel's support on Tuesday for its bid to promote the cholesterol-lowering pill Crestor to people with healthy cholesterol levels but have other risks of heart disease. The endorsement moves the company closer to winning ...
WASHINGTON (Reuters) - U.S. regulators see benefits to using an AstraZeneca Plc cholesterol drug in a vast new group of patients but will ask outside advisers to probe various safety issues, documents released on Friday said. AstraZeneca wants permission to promote the ...
Federal scientists say AstraZeneca's cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain. In documents posted online Friday, the Food and Drug Administration cites the findings ...
CHICAGO (Reuters) - Apparently healthy people with normal or even low cholesterol levels might benefit as much from taking statin drugs as people with high cholesterol, U.S. researchers said on Tuesday. They studied people with normal cholesterol readings but high levels of ...
Abbott and AstraZeneca seek US approval for cholesterol drug combining Crestor and TrilipixAbbott Laboratories and AstraZeneca PLC on Thursday asked the Food and Drug Administration to approve a drug that combines their cholesterol pills TriLipix and Crestor. Abbott's TriLipix is part of ...